Todd Watanabe
CIK: 0001801061
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Arcutis Biotherapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (33 total)
- Aug 3, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct4.4K shares at avg. $26.12$114K - May 4, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct3.2K shares at avg. $23.61$75K - Mar 2, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct1.1K shares at avg. $25.91$28K - Mar 2, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct36.3K shares at avg. $25.16$913K - Feb 27, 2026ARQT
Arcutis Biotherapeutics, Inc.
Award(A)Direct102K shares- - Feb 2, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct19.8K shares at avg. $25.50$506K - Nov 24, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct48.9K shares at avg. $30.36$1.5M - Nov 21, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct1.1K shares at avg. $30.00$32K - Nov 3, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct69 shares at avg. $25.40$2K - Nov 3, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct11.5K shares at avg. $24.71$284K - Oct 28, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct40K shares at avg. $25.03$1.0M - Oct 2, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct20.7K shares at avg. $20.04$416K - Oct 1, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct9.3K shares at avg. $20.02$185K - Oct 1, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct15K shares at avg. $18.91$284K - Sep 9, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct504 shares at avg. $17.52$9K - Sep 8, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct9.6K shares at avg. $17.54$169K - Aug 4, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct11.5K shares at avg. $14.33$165K - Jun 10, 2025ARQT
Arcutis Biotherapeutics, Inc.
Gift(G)Indirect997 shares- - Jun 10, 2025ARQT
Arcutis Biotherapeutics, Inc.
Gift(G)Direct997 shares- - Jun 10, 2025ARQT
Arcutis Biotherapeutics, Inc.
Gift(G)Indirect997 shares- - Jun 10, 2025ARQT
Arcutis Biotherapeutics, Inc.
Gift(G)Direct997 shares- - May 2, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct11.4K shares at avg. $15.19$174K - Mar 25, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct2.2K shares at avg. $17.56$38K - Mar 24, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct1.5K shares at avg. $17.52$26K - Mar 17, 2025ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct1.2K shares at avg. $17.61$21K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 4,375 | $26.12 | $114,261 | Direct |
| May 4, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 3,172 | $23.61 | $74,893 | Direct |
| Mar 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 1,068 | $25.91 | $27,676 | Direct |
| Mar 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 36,281 | $25.16 | $912,852 | Direct |
| Feb 27, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Award(A) | 102,000 | - | $0 | Direct |
| Feb 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 19,833 | $25.50 | $505,710 | Direct |
| Nov 24, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 48,945 | $30.36 | $1,485,755 | Direct |
| Nov 21, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 1,055 | $30.00 | $31,650 | Direct |
| Nov 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 69 | $25.40 | $1,753 | Direct |
| Nov 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 11,478 | $24.71 | $283,647 | Direct |
| Oct 28, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 40,000 | $25.03 | $1,001,032 | Direct |
| Oct 2, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 20,739 | $20.04 | $415,574 | Direct |
| Oct 1, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 9,261 | $20.02 | $185,372 | Direct |
| Oct 1, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 15,000 | $18.91 | $283,703 | Direct |
| Sep 9, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 504 | $17.52 | $8,829 | Direct |
| Sep 8, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 9,625 | $17.54 | $168,799 | Direct |
| Aug 4, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 11,547 | $14.33 | $165,429 | Direct |
| Jun 10, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Gift(G) | 997 | - | - | Indirect |
| Jun 10, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Gift(G) | 997 | - | - | Direct |
| Jun 10, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Gift(G) | 997 | - | - | Indirect |
| Jun 10, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Gift(G) | 997 | - | - | Direct |
| May 2, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 11,448 | $15.19 | $173,917 | Direct |
| Mar 25, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 2,171 | $17.56 | $38,131 | Direct |
| Mar 24, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 1,500 | $17.52 | $26,282 | Direct |
| Mar 17, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 1,200 | $17.61 | $21,137 | Direct |
1-25 of 33 transactions
About Watanabe Todd
Watanabe Todd (SEC CIK 0001801061) files insider reports with the SEC as Director of Arcutis Biotherapeutics, Inc. (ARQT).
Signal8 holds 19 ownership filings by Watanabe Todd, all Form 4s, filed between Nov 5, 2024 and Aug 5, 2026. Those filings report 33 transactions, from May 31, 2024 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Watanabe Todd's filings is in WESTLAKE VILLAGE, CA.
Recent filings by Watanabe Todd
- Aug 3, 2026: Open-market sale of ARQT shares (Form 4, code S).
- May 4, 2026: Open-market sale of ARQT shares (Form 4, code S).
- Mar 2, 2026: Open-market sales of ARQT shares (2 lines, Form 4, code S).
- Feb 27, 2026: Grant or award of ARQT shares (Form 4, code A).
- Feb 2, 2026: Open-market sale of ARQT shares (Form 4, code S).
Other insiders filing for Arcutis Biotherapeutics, Inc. (ARQT)
- SCOTT ROBERT A, Director
- Welgus Howard G., Director
- Matsuda Masaru
- Curran Terrie, Director
- Burnett Patrick
- Peetz Christopher, Director